Bellevue Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,327
| Closed | -$9.29M | – | 153 |
|
|
2024
Q4 | $9.29M | Sell |
50,327
-22,788
| -31% | -$4.21M | 0.18% | 81 |
|
|
2024
Q3 | $14.4M | Sell |
73,115
-159,587
| -69% | -$31.4M | 0.23% | 82 |
|
|
2024
Q2 | $48.1M | Buy |
232,702
+3,005
| +1% | +$621K | 0.78% | 32 |
|
|
2024
Q1 | $62.2M | Buy |
229,697
+11,941
| +5% | +$3.24M | 0.95% | 30 |
|
|
2023
Q4 | $51.5M | Sell |
217,756
-11,586
| -5% | -$2.74M | 0.79% | 38 |
|
|
2023
Q3 | $44.9M | Sell |
229,342
-85,171
| -27% | -$16.7M | 0.72% | 40 |
|
|
2023
Q2 | $66.1M | Buy |
314,513
+12,067
| +4% | +$2.54M | 0.94% | 32 |
|
|
2023
Q1 | $61M | Buy |
302,446
+12,469
| +4% | +$2.52M | 0.89% | 38 |
|
|
2022
Q4 | $63.2M | Buy |
289,977
+26,984
| +10% | +$5.88M | 0.84% | 36 |
|
|
2022
Q3 | $51.8M | Buy |
262,993
+31,924
| +14% | +$6.28M | 0.74% | 43 |
|
|
2022
Q2 | $49.4M | Buy |
231,069
+104,663
| +83% | +$22.4M | 0.7% | 46 |
|
|
2022
Q1 | $35.9M | Buy |
126,406
+60,495
| +92% | +$17.2M | 0.42% | 73 |
|
|
2021
Q4 | $24.8M | Buy |
65,911
+2,582
| +4% | +$973K | 0.26% | 95 |
|
|
2021
Q3 | $26.1M | Sell |
63,329
-114,941
| -64% | -$47.4M | 0.27% | 96 |
|
|
2021
Q2 | $65.9M | Sell |
178,270
-10,115
| -5% | -$3.74M | 0.64% | 54 |
|
|
2021
Q1 | $54.6M | Buy |
188,385
+45,367
| +32% | +$13.1M | 0.58% | 55 |
|
|
2020
Q4 | $35.7M | Sell |
143,018
-208,065
| -59% | -$52M | 0.41% | 70 |
|
|
2020
Q3 | $79.5M | Sell |
351,083
-14,750
| -4% | -$3.34M | 1.1% | 26 |
|
|
2020
Q2 | $63.8M | Buy |
365,833
+34,210
| +10% | +$5.96M | 0.9% | 29 |
|
|
2020
Q1 | $41.9M | Buy |
331,623
+48,525
| +17% | +$6.12M | 0.81% | 35 |
|
|
2019
Q4 | $43.2M | Buy |
283,098
+274,798
| +3,311% | +$42M | 0.69% | 42 |
|
|
2019
Q3 | $1.1M | Buy |
+8,300
| New | +$1.1M | 0.02% | 141 |
|